$10.200
-0.620 (-6.08%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de XERS por análisis de gráficos similares
Alphio's XERS stock price prediction model matches the current Xeris Biopharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.27 (+0.69%). The 1-week path is $10.37 (+1.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Xeris Biopharma Holdings Inc?
Xeris Biopharma (XERS) is a good buy right now due to its current price of $10.31 being significantly below the analyst price target of $14 to $16, indicating a potential upside of 36% to 55%. Additionally, the company has shown strong revenue growth, with Q2 2026 revenue reaching $92.1 million, a 29% year-over-year increase, and a gross margin of 83.47%, which reflects efficient operations. However, a risk to consider is the recent net loss of $31 million in Q2 2026, which could impact investor sentiment.
XERS cerró en $10.20 el Friday, tras bajar -6.08%
Xeris Biopharma Holdings Inc (XERS) last closed at $10.2, losing -6.08%. These facts feed the 1-day and 1-week XERS price prediction above.
Consenso de analistas
Xeris Biopharma Holdings Inc (XERS): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Xeris Biopharma Holdings Inc (XERS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de XERS, ordenadas por similitud.
Análisis de estacionalidad de XERS
Historically the probability of a positive October return for XERS is 100.00%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de XERS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $5.45 | $6.45 | $6.50 | -36.77% |
| Nov 2026 | $5.01 | $5.27 | $5.34 | -48.33% |
| Dec 2026 | $5.31 | $5.94 | $6.84 | -41.79% |
En 2026, se proyecta que Xeris Biopharma Holdings Inc (XERS) oscile entre $5.01 y $6.84.
Previsión mensual de Xeris Biopharma Holdings Inc para 2026
En Oct de 2026, se proyecta que Xeris Biopharma Holdings Inc promedie $6.45, con un mínimo de $5.45 y un máximo de $6.50.
En Nov de 2026, se proyecta que Xeris Biopharma Holdings Inc promedie $5.27, con un mínimo de $5.01 y un máximo de $5.34.
En Dec de 2026, se proyecta que Xeris Biopharma Holdings Inc promedie $5.94, con un mínimo de $5.31 y un máximo de $6.84.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.